Chemoinformaics analysis of (1R,5S)-2-methyl-5-(propan-2-yl)bicyclo[3.1.0]hex-2-ene
Molecular Weight | 136.238 | nRot | 1 |
Heavy Atom Molecular Weight | 120.11 | nRig | 7 |
Exact Molecular Weight | 136.125 | nRing | 2 |
Solubility: LogS | -3.98 | nHRing | 0 |
Solubility: LogP | 3.785 | No. of Aliphatic Rings | 2 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
Atoms Count | 26 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 1 |
No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 10 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
nHA | 0 | APOL | 27.3687 |
nHD | 0 | BPOL | 16.0513 |
QED | 0.486 |
Synth | 4.391 |
Natural Product Likeliness | 3.138 |
NR-PPAR-gamma | 0.003 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.001 |
HIA | 0.005 |
CACO-2 | -4.28 |
MDCK | 0.0000236 |
BBB | 0.696 |
PPB | 0.914769 |
VDSS | 1.979 |
FU | 0.0975813 |
CYP1A2-inh | 0.701 |
CYP1A2-sub | 0.453 |
CYP2c19-inh | 0.267 |
CYP2c19-sub | 0.914 |
CYP2c9-inh | 0.165 |
CYP2c9-sub | 0.414 |
CYP2d6-inh | 0.081 |
CYP2d6-sub | 0.583 |
CYP3a4-inh | 0.234 |
CYP3a4-sub | 0.289 |
CL | 16.534 |
T12 | 0.19 |
hERG | 0.014 |
Ames | 0.013 |
ROA | 0.072 |
SkinSen | 0.103 |
Carcinogencity | 0.463 |
EI | 0.983 |
Respiratory | 0.113 |
NR-Aromatase | 0.006 |
Antiviral | No |
Prediction | 0.906851 |